000 01447 a2200409 4500
005 20250516122753.0
264 0 _c20130809
008 201308s 0 0 eng d
022 _a1873-5126
024 7 _a10.1016/j.parkreldis.2012.10.016
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCapecci, Marianna
245 0 0 _aRest energy expenditure in Parkinson's disease: role of disease progression and dopaminergic therapy.
_h[electronic resource]
260 _bParkinsonism & related disorders
_cFeb 2013
300 _a238-41 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAntiparkinson Agents
_xtherapeutic use
650 0 4 _aBody Mass Index
650 0 4 _aCalorimetry, Indirect
650 0 4 _aCross-Sectional Studies
650 0 4 _aDisease Progression
650 0 4 _aEnergy Metabolism
_xdrug effects
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aParkinson Disease
_xdrug therapy
650 0 4 _aRest
_xphysiology
700 1 _aPetrelli, Massimiliano
700 1 _aEmanuelli, Benedetta
700 1 _aMillevolte, Marzia
700 1 _aNicolai, Albano
700 1 _aProvinciali, Leandro
700 1 _aCeravolo, Maria Gabriella
773 0 _tParkinsonism & related disorders
_gvol. 19
_gno. 2
_gp. 238-41
856 4 0 _uhttps://doi.org/10.1016/j.parkreldis.2012.10.016
_zAvailable from publisher's website
999 _c22292416
_d22292416